Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019023769) USE OF STEROIDAL GLYCOSIDES, PHARMACEUTICAL FORMULATIONS, USE OF FURCRAEA FOETIDA PLANT EXTRACTS, PROCESS FOR PRODUCING FURCRAEA FOETIDA PLANT EXTRACTS AND METHOD FOR TREATING SKIN DISORDERS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/023769 International Application No.: PCT/BR2018/050181
Publication Date: 07.02.2019 International Filing Date: 01.06.2018
IPC:
C07J 71/00 (2006.01) ,A61K 31/7048 (2006.01) ,A61K 36/886 (2006.01) ,A61P 17/06 (2006.01) ,A61P 17/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
J
STEROIDS
71
Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7042
Compounds having saccharide radicals and heterocyclic rings
7048
having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18
Magnoliophyta (angiosperms)
88
Liliopsida (monocotyledons)
886
Aloeaceae (Aloe family), e.g. aloe vera
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17
Drugs for dermatological disorders
06
Antipsoriatics
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17
Drugs for dermatological disorders
Applicants:
GOMES, Lisis Rojo [BR/BR]; BR
PIANOWSKI, Luiz F. [BR/BR]; BR
Inventors:
GOMES, Lisis Rojo; BR
PIANOWSKI, Luiz F.; BR
Agent:
GAIARSA, Lucas M.; BR
Priority Data:
BR 10 2017 016550 701.08.2017BR
Title (EN) USE OF STEROIDAL GLYCOSIDES, PHARMACEUTICAL FORMULATIONS, USE OF FURCRAEA FOETIDA PLANT EXTRACTS, PROCESS FOR PRODUCING FURCRAEA FOETIDA PLANT EXTRACTS AND METHOD FOR TREATING SKIN DISORDERS
(FR) UTILISATION DE GLYCOSIDES STÉROÏDIENS, FORMULATIONS PHARMACEUTIQUES, UTILISATION D’EXTRAITS DE LA PLANTE FURCRAEA FOETIDA, PROCÉDÉ D’OBTENTION D'EXTRAITS DE LA PLANTE FURCRAEA FOETIDA ET MÉTHODE DE TRAITEMENT D’AFFECTIONS CUTANÉES
(PT) USO DE GLICOSÍDEOS ESTEROIDAIS, FORMULAÇÕES FARMACÊUTICAS, USO DE EXTRATOS DA PLANTA FURCRAEA FOETIDA, PROCESSO DE OBTENÇÃO DE EXTRATOS DA PLANTA FURCRAEA FOETIDA E MÉTODO DE TRATAMENTO DE DISTÚRBIOS DA PELE
Abstract:
(EN) The present invention relates, most generally, to steroidal glycosides that can be used for treating skin disorders. Particularly, the invention relates to the use of certain steroidal glycosides, per se or in the form of aglycone, spirostanol derivatives, or the precursor thereof, furastanol, or mixtures thereof, used in treating skin disorders, for example, psoriasis. The invention also relates to formulations containing steroidal glycosides, to the process for producing Furcraea foetida plant extract, and to a method for treating skin disorders.
(FR) La présente invention concerne, dans sa généralité la plus large, des glycosides stéroïdiens utiles dans le traitement d'affections cutanées. Plus particulièrement, l'invention concerne l'utilisation de certains glycosides stéroïdiens per se ou sous forme aglicone, dérivés de spirostanol, de son précurseur furastanol ou de mélanges de ceux-ci, utilisés dans le traitement d'affections cutanées telles que, par exemple, le psoriasis. L’invention concerne également des formulations contenant des glicosides stéroïdiens, un procédé d’obtention d’un extrait de la plante Furcraea foetida, et une méthode de traitement d'affections cutanées.
(PT) A presente invenção refere-se, em sua generalidade mais ampla, a glicosídeos esteroidais úteis no tratamento de distúrbios da pele. De forma particular, a invenção refere-se ao uso de certos glicosídeos esteroidais, per se ou na forma aglicona, derivados de espirostanol, de seu precursor furastanol, ou misturas desses, utilizados no tratamento de distúrbios da pele, por exemplo, psoríase. A invenção refere-se ainda a formulações contendo glicosídeos esteroidais, ao processo de obtenção de extrato da planta Furcraea foetida, e a método de tratamento de distúrbios da pele.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Portuguese (PT)
Filing Language: Portuguese (PT)